Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Tumbleweed67on Jan 26, 2011 4:27pm
398 Views
Post# 18030897

RE: RE: Tension you could cut with a knife

RE: RE: Tension you could cut with a knifeBaylor, perhaps their lack of response is an indication of them being in possession of "material information". News tomorrow maybe?

https://www.stockhouse.com/Bullboards/MessageDetail.aspx?s=SSS&t=LIST&m=29111334&l=0&pd=0&r=0

I don't recall...is there a prize if I was right? LOL
GLTA
TW
Bullboard Posts